<DOC>
	<DOCNO>NCT00817596</DOCNO>
	<brief_summary>Clinical evaluation safety efficacy Prometra Programmable Infusion Pump accurately supply drug intrathecal space treatment chronic pain .</brief_summary>
	<brief_title>Prometra 's Utilization Mitigating Pain ( PUMP )</brief_title>
	<detailed_description>Chronic condition pain spasticity major challenge traditional medical treatment . Chronic pain spasticity seriously reduce quality life restrict normal daily activity many people . The first line defense normally oral medication . However , significant number patient require additional alternative therapy due side effect oral medication intractable nature condition . In 1979 , Wand et . al . find small amount morphine , inject sub-arachnoid space , significant affect reduce pain . Since time number drug product infusion pump develop address condition . The primary drug use purpose preservative-free morphine sulfate solution deliver via implanted intrathecal catheter . The Prometra Intrathecal Pump System second programmable pump use treatment chronic pain .</detailed_description>
	<mesh_term>Pain , Intractable</mesh_term>
	<criteria>suffer chronic pain 18 year age old life expectancy &gt; 6 month failure respond less invasive method patient undergone successful morphine trial patient agree Protocol requirement patient consider good subject per clinician Existing spinal problem prevent treatment systemic infection patient pregnant breast feed know allergy sensitivity material coexist medical condition precludes pump usage subject require MRI post procedure subject unwilling/unable comply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2012</verification_date>
</DOC>